North America Antibiotics Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Drug Class (Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others); Action Mechanism (Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors); and Country
The North America antibiotics market is expected to reach US$ 18,004.25 millionby 2027 from US$ 13,527.79 million in 2019. The market is estimated to grow with a CAGR of 3.9% from 2020 to 2027.
The growth of the market is driven by factors such as prevalence of infectious diseases and increasing development of generic drugs in the North America region. However, tedious and expensive process of antibiotic development andthe impact of COVID-19 pandemic are likely to restrain the market growth to a certain extent.
Antibiotics refer to a class of medicines containing substances that are active against bacteria. These medicines either kill the bacteria or control the infection by inhibiting the bacterial reproduction, which in turn helps patient to recover. Antibiotics are specific to the type of bacteria being treated and are not able to be interchanged from one infection to another.
Generic versions are introduced in market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. For instance, in June 2018, Lupin launched generic Tobramycin inhalation solution in the US market. Moreover, encouragement from government authorities is also projected to drive the production of generic antibiotics, which would eventually drive the growth of the North America antibiotics market during the forecast period.
The health systems are witnessing considerable growth in the prevalence of drug resistant bacterial infections. With various environmental factors, such as exposure to antibiotics and spontaneous mutations, bacteria are becoming highly resistant to a large number of antibiotics, and a few new antibiotics are under development in order to deal with these new bacteria strains. To combat such critical conditions, several governments and healthcare authorities are implementing constructive strategies. For instance, antibiotic resistance is a national priority, and the US government has taken ambitious steps to fight this threat. For instance, US government established a US National Strategy for Combating Antibiotic-Resistant Bacteria (National Strategy) and an accompanying US National Action Plan for Combating Antibiotic-Resistant Bacteria (National Action Plan).
Research institutes, pharmaceutical, and biotech companies are engaged in collaborative work to address the COVID-19 outbreak. This has eventually shifted their focus from development of new antibiotics to vaccine development for COVID-19. Moreover, diversion of resources from antibiotics development to COVID-19 treatment is likely to hamper overall productivity of the drug development during the forecast period. Furthermore, pharmaceutical supplies and procurement are also badly affected by the outbreak of COVID-19 in North America.
Mexico Antibiotics Market Revenue and Forecasts to 2027 (US$Mn)
Get more information on this report :
NORTH AMERICAANTIBIOTICS MARKET SEGMENTATION
By Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolones
- Macrolides
- Carbapenem
- Aminoglycosides
- Sulfonamides
- Others
By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
By Country
- US
- Canada
- Mexico
Companies Mentioned
- Johnson & Johnson Services, Inc
- Bristol-Myers Squibb Company
- Eli Lilly and Company.
- Abbott
- Pfizer Inc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Antibiotics Market – By Drug Class
1.3.2 North America Antibiotics Market – By Action Mechanism
1.3.3 North America Antibiotics Market – By Country
2. North America Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Antibiotics Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Antibiotics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Bacterial Infections
5.1.2 Increasing Development of Generic Drugs
5.2 Key Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Growing Investments to Combat Antimicrobial Resistance
5.4 Future Trends
5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
5.5 Impact analysis
6. Antibiotics Market – North America Analysis
6.1 North America Antibiotics Market Revenue Forecasts and Analysis
7. North America Antibiotics Market Analysis And Forecasts To 2027 – By Drug Class
7.1 Overview
7.2 North America Antibiotics market, By Drug Class 2019 & 2027 (%)
7.2.1 North America Antibiotics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)
7.3 Sulfonamides
7.3.1 Overview
7.3.2 North America Sulfonamides Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Aminoglycosides
7.4.1 Overview
7.4.2 North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Carbapenem
7.5.1 Overview
7.5.2 North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Macrolides
7.6.1 Overview
7.6.2 North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Fluoroquinolones
7.7.1 Overview
7.7.2 North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Penicillin
7.8.1 Overview
7.8.2 North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cephalosporins
7.9.1 Overview
7.9.2 North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Others
7.10.1 Overview
7.10.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Antibiotics Market Analysis – By Action Mechanism
8.1 Overview
8.2 North America Antibiotics Market, By Action Mechanism 2019-2027 (%)
8.2.1 North America Antibiotics Market Revenue and Forecasts to 2027, By Action Mechanism (US$ Mn)
8.3 Mycolic Acid Inhibitors
8.3.1 Overview
8.3.2 North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 RNA Synthesis Inhibitors
8.4.1 Overview
8.4.2 North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 DNA Synthesis Inhibitors
8.5.1 Overview
8.5.2 North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Protein Synthesis Inhibitors
8.6.1 Overview
8.6.2 North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cell Wall Synthesis Inhibitors
8.7.1 Overview
8.7.2 North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Antibiotics Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 North America Antibiotics Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.4 North America: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.5 North America: Antibiotics Market, by Country, 2019 & 2027 (%)
9.1.6 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.6.3 US: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.7 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.7.3 Canada: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
9.1.8 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Antibiotics Market, by Drug Class, 2018–2027 (USD Million)
9.1.8.3 Mexico: Antibiotics Market, by Action Mechanism, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Antibiotics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Pfizer Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson Services, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Eli Lilly and Company.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Abbott
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Word Index
LIST OF TABLES
Table 1. North America Antibiotics Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)
Table 2. North America Antibiotics Market Revenue and Forecasts To 2027, By Action Mechanism (US$ Mn)
Table 3. North America Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 5. US Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 6. US Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico Antibiotics Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Antibiotics Market, by Action Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 11. List of Abbreviation
LIST OF FIGURES
Figure 1. Antibiotics Market Segmentation
Figure 2. North America Antibiotics Market Overview
Figure 3. Cephalosporin Segment Held Largest Share of Product in Antibiotics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Antibiotics Market - Leading Country Markets (US$ Mn)
Figure 6. Antibiotics Market - North America PEST Analysis
Figure 7. Antibiotics market impact analysis of driver and restraints
Figure 8. North America Antibiotics market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Antibiotics market, By Drug Class 2019 & 2027 (%)
Figure 10. North America Sulfonamides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Aminoglycosides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Carbapenem Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Macrolides Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Fluoroquinolones Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Penicillin Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Cephalosporins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Antibiotics Market, by Action Mechanism 2019 & 2027 (%)
Figure 19. North America Mycolic Acid Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America RNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America DNA Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Protein Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Cell Wall Synthesis Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America: Antibiotics Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. North America Antibiotics Market Revenue and Forecast to 2027 (USD Million)
Figure 27. North America: Antibiotics Market, by Country, 2019 & 2027 (%)
Figure 28. US: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Canada: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Mexico: Antibiotics Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of Covid-19 Pandemic In North American Country Markets
The List of Companies - North America Antibiotics Market
- Johnson & Johnson Services, Inc
- Bristol-Myers Squibb Company
- Eli Lilly and Company.
- Abbott
- Pfizer Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Antibiotics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.